Date published: 2026-3-20

1-800-457-3801

SCBT Portrait Logo
Seach Input

NOC-12 (CAS 146724-89-2)

5.0(1)
Write a reviewAsk a question

See product citations (3)

Alternate Names:
3-Ethyl-3-(ethylaminoethyl)-1-hydroxy-2-oxo-1-triazene
Application:
NOC-12 is a diazeniumdiolate NO donor
CAS Number:
146724-89-2
Purity:
≥97%
Molecular Weight:
176.22
Molecular Formula:
C6H16N4O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

NOC-12 is a diazeniumdiolate (NONOate) small molecule NO donor with a long NO release half-life of 327 minutes at 22degC. NOC-12 presents an NO donor with a half-life of release intermediate between NOC-9 (sc-202250, half-life 2.7 min) and NOC-18 (sc-202247, half-life 20 hr). NO release from NOC-12 and NOC-18 demonstrated inhibition of pulmonary artery smooth muscle cell proliferation with associated cGMP increase. NOC-12 mediated NO-release was shown to increase cGMP levels and protect cells against H2O2-induced damage and reperfusion.


NOC-12 (CAS 146724-89-2) References

  1. Lack of interaction between nitric oxide and the redox modulatory site of the NMDA receptor.  |  Aizenman, E. and Potthoff, WK. 1999. Br J Pharmacol. 126: 296-300. PMID: 10051148
  2. Role of nitric oxide in regulating neonatal porcine pulmonary artery smooth muscle cell proliferation.  |  Ambalavanan, N., et al. 1999. Biol Neonate. 76: 291-300. PMID: 10516396
  3. Activation of cGMP-dependent protein kinase Ialpha is required for N-methyl-D-aspartate- or nitric oxide-produced spinal thermal hyperalgesia.  |  Tao, YX. and Johns, RA. 2000. Eur J Pharmacol. 392: 141-5. PMID: 10762667
  4. The nitric oxide donor NOC12 protects cultured astrocytes against apoptosis via a cGMP-dependent mechanism.  |  Takuma, K., et al. 2002. Jpn J Pharmacol. 89: 64-71. PMID: 12083744
  5. Nitric oxide, NOC-12, and S-nitrosoglutathione modulate the skeletal muscle calcium release channel/ryanodine receptor by different mechanisms. An allosteric function for O2 in S-nitrosylation of the channel.  |  Sun, J., et al. 2003. J Biol Chem. 278: 8184-9. PMID: 12509428
  6. Retinal neuronal death induced by intraocular administration of a nitric oxide donor and its rescue by neurotrophic factors in rats.  |  Takahata, K., et al. 2003. Invest Ophthalmol Vis Sci. 44: 1760-6. PMID: 12657619
  7. Evidence that nitric oxide regulates the acute effects of ethanol on rat N-methyl-D-aspartate receptors in vitro.  |  Costa, ET., et al. 2003. Neurosci Lett. 343: 41-4. PMID: 12749993
  8. Nitric oxide enhances osteoclastogenesis possibly by mediating cell fusion.  |  Nilforoushan, D., et al. 2009. Nitric Oxide. 21: 27-36. PMID: 19389479
  9. Hsp90β inhibition modulates nitric oxide production and nitric oxide-induced apoptosis in human chondrocytes.  |  Calamia, V., et al. 2011. BMC Musculoskelet Disord. 12: 237. PMID: 22004293
  10. Role of new agents affecting NO/cGMP pathway on ovalbumin-sensitized guinea pig trachea.  |  Parlak, A., et al. 2012. Exp Lung Res. 38: 420-6. PMID: 23030645
  11. Nitric oxide compounds have different effects profiles on human articular chondrocyte metabolism.  |  de Andrés, MC., et al. 2013. Arthritis Res Ther. 15: R115. PMID: 24025112
  12. Signaling Mechanisms in the Nitric Oxide Donor- and Amphetamine-Induced Dopamine Release in Mesencephalic Primary Cultured Neurons.  |  Salum, C., et al. 2016. Neurotox Res. 29: 92-104. PMID: 26391887
  13. The nitric oxide-cyclic guanosine monophosphate pathway inhibits the bladder ATP release in response to a physiological or pathological stimulus.  |  Okuyama, E., et al. 2021. Physiol Rep. 9: e14938. PMID: 34288526

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

NOC-12, 10 mg

sc-202246
10 mg
$260.00